Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

1. Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects

   Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi +6

   МақолаCircular RNAs in diseasesClinical and Experimental Medicine20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000780

2. Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects

   Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi +6

   МақолаCancer-related molecular mechanisms researchCancer Treatment and Research Communications20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005222

3. Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis

   Qamar Abuhassan, Ahmed Faisal Mutee, Abdulkareem Shareef +10

   МақолаPancreatic and Hepatic Oncology ResearchClinica Chimica Acta20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.011933